本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德納維製藥

15.50
0.0000
成交量:- -
成交額:1.10億
市值:17.67億
市盈率:-43.12
高:15.50
開:15.50
低:15.50
收:15.50
52周最高:15.73
52周最低:9.20
股本:1.14億
流通股本:1.14億
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.3595
每股收益(LYR):0.2000
淨資產收益率:-7.14%
總資產收益率:1.20%
市淨率:3.31
市盈率(LYR):77.50

資料載入中...

2020/02/14

重要事件披露

Current report, item 5.02
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

重要事件披露

Current report, item 5.02
2019/12/16

重要事件披露

Current report, item 5.02
2019/12/03

重要事件披露

Current report, item 8.01
2019/11/18

重要事件披露

Current report, item 5.02
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/04

重要事件披露

[Amend] Current report, item 5.02
2019/10/04

重要事件披露

Current report, item 5.02
2019/09/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/23

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/22

超過5%披露

General statement of acquisition of beneficial ownership
2019/08/22

持股變動聲明

Initial statement of beneficial ownership of securities